Daily non-political popular news in brief.
Biopharmaceutical infrastructure key to lower drug development costs
10-11-2007 · EurekAlert!Improvements to the technology infrastructure for researching and developing new biopharmaceuticals would be expected to save the industry hundreds of millions of dollars annually, according to a new economic study sponsored by NIST.
Read more »
Keywords: biopharmaceutical, infrastructure, key, lower, drug, development, costs, cost
« Previous | Next »
Similar news on "Biopharmaceutical infrastructure key to lower drug development costs":
- Increase in prescription drug cost sharing associated with lower rates of drug treatment, adherence
07-03-2007 · EurekAlert!
A review of previous studies indicates that an increase in prescription drug cost sharing is associated with a decrease in drug spending and use of pharmacies; and for some chronic conditions, higher cost sharing is associated with greater use of expensive medical services, according to an article in the July 4 issue of JAMA.
Similar news · Read more »
- New forecasting tool could reduce drug development costs
02-01-2007 · EurekAlert!
It now costs more than $800 million to develop a new drug. But what if pharmaceutical companies could predict which experimental drugs will ultimately get FDA approval, and which will ultimately fail? Researchers present a forecasting model that could potentially save hundreds of millions of dollars per new drug. They also urge more data sharing by the drug industry to improve the accuracy of forecasting, allowing more medical discoveries to be brought to the bedside.
Similar news · Read more »
- Jefferson scientists find protein may be key in developing deadly form of pancreatic cancer
10-11-2007 · EurekAlert!
A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers have discovered that the protein pp32 -- which normally applies the brakes on a cancer-causing gene -- is missing in an aggressive form of pancreatic cancer. Though the work is preliminary, the scientists say, the absent protein could eventually become a marker for the disease and a potential drug target.
Similar news · Read more »
- New study looks at long-term drug costs for treating AIDS in Brazil
11-12-2007 · EurekAlert!
AIDS continues to be a staggering global public health problem. However, little is known about the long-term costs associated with providing drugs to AIDS patients in developing countries. To study those long-term cost trends, researchers from the Harvard School of Public Health have performed the first detailed analysis of AIDS drug cost trends in Brazil.
Similar news · Read more »
- CAM-oriented primary care providers result in cost savings, high patient satisfaction
06-07-2007 · EurekAlert!
Patients visiting chiropractors and other holistically-oriented physicians who serve as primary care physicians have lower utilization costs and higher patient satisfaction levels than patients treated by conventional medical doctors, according to a recent study.
Similar news · Read more »
- Fuel cell development bolstered by ORNL, Julich agreement
07-10-2007 · Oak Ridge National Laboratory (ORNL)
An agreement between Oak Ridge National Laboratory and Research Centre Julich in Germany could ultimately lead to lower cost, higher performance fuel cells for transportation and portable power applications.
Similar news · Read more »
- Research links 'ecstasy' to survival of key movement-related cells in brain
10-18-2006 · EurekAlert!
New research from the University of Cincinnati suggests that the widely abused club drug "ecstasy," or MDMA, can increase the survival of dopamine cells in the brain during fetal development. Because these cells are critical in the regulation of voluntary movement, the findings, the researchers say, may lead to better therapies for neurological diseases like Parkinson's.
Similar news · Read more »
- Pint-sized car engine promises high efficiency
10-25-2006 · Massachusetts Institute of Technology (MIT)
MIT researchers are developing a half-sized gasoline engine that performs like its full-sized cousin but offers fuel efficiency approaching that of today's hybrid engine system--at a far lower cost. The key? Carefully controlled injection of ethanol.
Similar news · Read more »
- Split the difference: Pill-splitting study looks at cost-saving step that could be used by millions
06-11-2007 · EurekAlert!
Slicing certain pills in half could slice a hefty amount off of Americas prescription drug costs. While only some types of pills can be split safely, they include popular cholesterol-lowering drugs. Now, the first prospective randomized controlled trial of pill-splitting gives more evidence of how the practice could be used.
Similar news · Read more »
- MIT's pint-sized engine promises high efficiency, low cost
10-27-2006 · EurekAlert!
MIT researchers are developing a half-sized gasoline engine that performs like its full-sized cousin but offers fuel efficiency approaching that of today's hybrid engine system -- at a far lower cost. The key? Carefully controlled injection of ethanol, an increasingly common biofuel, directly into the engine's cylinders when there's a hill to be climbed or a car to be passed.
Similar news · Read more »
